Jeil Pharm (002620) — Cash Flow Reinvestment Rate
Jeil Pharm (002620) has a Cash Flow Reinvestment Rate of 8.93x as of March 2026, reinvesting ₩3.99 Billion (capex ₩1.72 Billion plus investments ₩-2.27 Billion) from operating cash flow of ₩447.08 Million. Check earnings quality score of Jeil Pharm to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Jeil Pharm Cash Flow Reinvestment Rate (2011–2025)
Historical reinvestment intensity for Jeil Pharm across 8 annual periods. Explore Jeil Pharm (002620) investment intensity to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Jeil Pharm (2011–2025)
Year-by-year capital reinvestment analysis for Jeil Pharm. For live market cap and broader valuation context, see market value of Jeil Pharm.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 41.01x | ₩16.00 Billion | ₩390.26 Million | ₩9.33 Billion | ▲ +1111.8% |
| 2024 | 3.38x | ₩15.37 Billion | ₩4.54 Billion | ₩6.86 Billion | ▲ +32.6% |
| 2021 | 2.55x | ₩34.19 Billion | ₩13.40 Billion | ₩23.69 Billion | ▲ +44.8% |
| 2019 | 1.76x | ₩44.43 Billion | ₩25.22 Billion | ₩37.69 Billion | ▲ +107.5% |
| 2017 | 0.85x | ₩5.03 Billion | ₩5.92 Billion | ₩2.94 Billion | ▼ -84.0% |
| 2016 | 5.30x | ₩60.20 Billion | ₩11.36 Billion | ₩30.33 Billion | ▲ +87.4% |
| 2015 | 2.83x | ₩7.76 Billion | ₩2.74 Billion | ₩6.74 Billion | ▲ +159.0% |
| 2011 | 1.09x | ₩25.82 Billion | ₩23.63 Billion | ₩22.40 Billion | — |